Contact details Bariatric Co-ordinators: Bariatric Clinical Nurse Specialist: 0117 414 7557 If you or the individual you are caring for need support reading this information please ask a member of staff for advice
Simultaneously, Novo Nordisks SELECT trial confirmed a 20% reduction in major adverse cardiac events with semaglutide, expanding prescriber confidence and unlocking reimbursement across high-risk populations
[1] [2] Marketed under brand names including Ozempic, Wegovy, and Rybelsus, semaglutide works by mimicking the action of the naturally occurring hormone GLP-1, which enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety
Outstanding service and product every time
You are not injecting daily
GLP-1 receptors are present in Sertoli and Leydig cells, which means that these drugs have the potential to directly affect testicular function in addition to improving hormonal balance